520A Stock Chart & Stats
$285.00
-$10.00(-3.39%)
―
--
Day’s Range― - ―
52-Week Range$271.00 - $809.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
¥5.13B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,984,646
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
J-Pharma Co.,Ltd. News
520A FAQ
What was J-Pharma Co.,Ltd.’s price range in the past 12 months?
J-Pharma Co.,Ltd. lowest stock price was $271.00 and its highest was $809.00 in the past 12 months.
What is J-Pharma Co.,Ltd.’s market cap?
J-Pharma Co.,Ltd.’s market cap is ¥5.13B.
When is J-Pharma Co.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were J-Pharma Co.,Ltd.’s earnings last quarter?
Currently, no data Available
Is J-Pharma Co.,Ltd. overvalued?
According to Wall Street analysts J-Pharma Co.,Ltd.’s price is currently Undervalued.
Does J-Pharma Co.,Ltd. pay dividends?
J-Pharma Co.,Ltd. does not currently pay dividends.
What is J-Pharma Co.,Ltd.’s EPS estimate?
J-Pharma Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does J-Pharma Co.,Ltd. have?
J-Pharma Co.,Ltd. has 17,984,646 shares outstanding.
What happened to J-Pharma Co.,Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of J-Pharma Co.,Ltd.?
Currently, no hedge funds are holding shares in JP:520A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AnGes
―
Solasia Pharma KK
―
Nippon Chemiphar Co., Ltd.
―
JCR Pharmaceuticals Co., Ltd.
―
Delta-Fly Pharma, Inc.
―